Ticker

EQS-News: Shelly Group accelerates expansion into professional market segments using globally established hardware and software standards

Retrieved on: 
Mercredi, avril 10, 2024
Automation, Heat, Light, Internet of things, Installation (computer programs), Air conditioning, Ventilation, DNA, Light + Building, KNX, Lighting, Ticker

Sofia / Munich, 13 March 2024 – Shelly Group AD (Ticker: SLYG / ISIN: BG1100003166 ) (“Shelly Group” / “the Company“), a provider of IoT and smart building solutions based in Sofia, Bulgaria, is accelerating its expansion into professional market segments.

Key Points: 
  • Sofia / Munich, 13 March 2024 – Shelly Group AD (Ticker: SLYG / ISIN: BG1100003166 ) (“Shelly Group” / “the Company“), a provider of IoT and smart building solutions based in Sofia, Bulgaria, is accelerating its expansion into professional market segments.
  • To this end, Shelly announced the integration of globally established hardware and software standards at Light + Building 2024, the world's leading expo for lighting and building technology.
  • In addition, Shelly is launching a new free tool that connects end customers in the German market with electricians for the installation of their products.
  • In this way, we increase customer and professional user loyalty and strengthen our market penetration and competitive position.“

EQS-News: beaconsmind Group: First Berlin continues to rate beaconsmind share as 'Buy' – Price target EUR 14.00

Retrieved on: 
Mercredi, avril 10, 2024
EUR, Software as a service, Wi-Fi, XETRA, CHF, Ticker, Gesellschaft mit beschränkter Haftung

The rating for beaconsmind stock remains unchanged at "Buy" with a target price of EUR 14.00.

Key Points: 
  • The rating for beaconsmind stock remains unchanged at "Buy" with a target price of EUR 14.00.
  • With this target price, First Berlin sees significant price potential of approximately 190%.
  • According to First Berlin, future M&A activities, among other things, are not yet sufficiently reflected in the current price level.
  • The current report by First Berlin on beaconsmind is available for download on the corporate website of beaconsmind www.beaconsmind.com in the "Investor Relations" section.

EQS-News: Successful completion of preset purchase plan for the acquisition of Northern Data Group shares by CEO Aroosh Thillainathan

Retrieved on: 
Mercredi, avril 10, 2024
EUR, Acquisition, Ticker, OTC, NB2

Acquisition of further 208,348 Northern Data shares for a total purchase price of approx.

Key Points: 
  • Acquisition of further 208,348 Northern Data shares for a total purchase price of approx.
  • EUR 5.9 million by Mr. Thillainathan via his family office ART Beteiligungs Management GmbH in the period from 4 to 19 March 2024
    In total, acquisition of 1,062,490 Northern Data shares for a total purchase price of approx.
  • EUR 30 million in the period from 8 January 2024 to the completion of the standing order on 19 March 2024
    Mr. Thillainathan’s stake in Northern Data Group thereby increased to 3,823,806 shares, corresponding to approx.
  • 7.15% of the current share capital
    Frankfurt/Main – 21 March 2024 – Northern Data AG (‘Northern Data Group’; Ticker symbol German stock market: NB2 , ISIN: DE000A0SMU87 ) today announces the successful completion and the results of its CEO Aroosh Thillainathan's preset share purchase plan.

Charwood Energy: Charwood Energy signs a new order for a biomass boiler for a sawmill in Ille-et-Vilaine (France)

Retrieved on: 
Mercredi, avril 10, 2024
Automation, Saint-Sauveur-des-Landes, Ille-et-Vilaine, Ticker, Biomass, Renewable energy

Charwood Energy (ISIN: FR001400AJ60, Ticker: ALCWE), a French company specializing in tailor-made solutions for the energy valorization of biomass, today announced the signing of a contract for the installation and commissioning of a biomass boiler for a sawmill in the Ille-et-Vilaine region of France.

Key Points: 
  • Charwood Energy (ISIN: FR001400AJ60, Ticker: ALCWE), a French company specializing in tailor-made solutions for the energy valorization of biomass, today announced the signing of a contract for the installation and commissioning of a biomass boiler for a sawmill in the Ille-et-Vilaine region of France.
  • The contract covers the replacement and modernization of a heating system used to dry lumber and timber at a sawmill in Saint-Sauveur-des-Landes, Ille-et-Vilaine.
  • The existing heating system will be replaced by a 900 kW high-performance unit that will use biomass made up of bark and woody material as fuel, using technology developed by Charwood Energy.
  • Charwood Energy will provide a wide range of services for this new installation, including the retrofitting of ducting, power supply and automation of the heating system.

EQS-News: MEDICLIN achieves consolidated Group sales of EUR 730.1 million in 2023 - outlook for 2024 is positive

Retrieved on: 
Mercredi, avril 10, 2024
EUR, WKN, CFO, Coronavirus, Sale, Bad, MED, Ticker, Rehabilitation, Lithium

At Group level, sales of EUR 730.1 million were achieved, an increase of 3.6% compared to 2022.

Key Points: 
  • At Group level, sales of EUR 730.1 million were achieved, an increase of 3.6% compared to 2022.
  • At EUR 12.7 million, the Group operating result was EUR 6.8 million below the previous year's figure (2022: EUR 19.5 million) due to a one-off effect.
  • Sales include services from the protective shield totalling EUR 7.4 million, which is less than in 2022 (EUR 11.7 million).
  • Sales in the acute segment totalled EUR 254.0 million, an increase of EUR 1.3 million or 0.5% compared to the previous year.

EQS-News: APONTIS PHARMA expects profitable growth again in 2024

Retrieved on: 
Mercredi, avril 10, 2024
EUR, Annual report, Tax, Marketing, Ticker, Growth, Physician, Depreciation, Pharmaceutical industry

APONTIS PHARMA closed the 2023 financial year with a consolidated net loss of EUR 11.3 million (2022: consolidated net income of EUR 2.7 million).

Key Points: 
  • APONTIS PHARMA closed the 2023 financial year with a consolidated net loss of EUR 11.3 million (2022: consolidated net income of EUR 2.7 million).
  • Bruno Wohlschlegel, Chief Executive Officer of APONTIS PHARMA AG: “The 2023 financial year was characterized by significant changes for APONTIS PHARMA.
  • Following the successful implementation of the performance and efficiency improvement program earlier than planned, APONTIS PHARMA has laid the foundations for future profitable growth in Single Pill combinations.
  • As such, we launched our 15th Single Pill combination on the German market in March and continue to see considerable growth potential for Single Pill combinations from APONTIS PHARMA.

Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group.

Retrieved on: 
Mercredi, avril 10, 2024
Wealth, Aix-en-Provence, TP ICAP, TP, Ticker, Medtech, Security (finance)

Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group.

Key Points: 
  • Affluent Medical announces coverage initiation of its stock by Gilbert Dupont – Société Générale Group.
  • Aix-en-Provence, 4 April 2024 - 5:45 pm - Affluent Medical (ISIN: FR0013333077 – Ticker: AFME), a French clinical-phase MedTech company specializing in the international development and industrialization of innovative medical prostheses, announces today that Gilbert Dupont – Société Générale Group has initiated coverage of its stock.
  • Gilbert Dupont – Société Générale Group began covering the stock with a study entitled "Un pour tous, tous pour un" ("one for all and all for one"), published on 3 April 2024.
  • In this study, Gilbert Dupont – Société Générale Group recommended buying the stock, with a target price of €3.30, representing a potential upside of 89% compared with the closing price on 2 April 2024.

EQS-News: Northern Data Group Publishes Consolidated Financial Statements for the Year Ended December 31, 2022

Retrieved on: 
Mercredi, avril 10, 2024
Cloud, Frankfurt, EUR, Digital asset, Capital market, Ticker, High, Annual report, NB2, Cryptocurrency

Northern Data Group Publishes Consolidated Financial Statements for the Year Ended December 31, 2022

Key Points: 
  • Northern Data Group Publishes Consolidated Financial Statements for the Year Ended December 31, 2022
    The issuer is solely responsible for the content of this announcement.
  • Northern Data Group Publishes Consolidated Financial Statements for the Year Ended December 31, 2022
    Frankfurt/Main – March 22, 2024 – Northern Data Group (“Northern Data AG”; Ticker symbol German stock market: NB2 , ISIN: DE000A0SMU87 ) today published its key financial figures as well as the audited annual financial statements and audited consolidated financial statements for the 2022 financial year.
  • The Group spreads its revenue streams across its three application areas for High Performance-Computing – Cloud Services, Data Center Infrastructure, and Digital Assets.
  • The 2022 Annual Report, as well as a summary of the financial figures for 2022, are available in the IR section of the Group's website .

Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.

Retrieved on: 
Mercredi, avril 10, 2024
TP, Wealth, Aix-en-Provence, Ticker, Medtech

Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.

Key Points: 
  • Affluent Medical announces coverage initiation of its stock by TP ICAP Midcap.
  • Aix-en-Provence, 28 March 2024 - 5:45 pm - Affluent Medical (ISIN: FR0013333077 – Ticker: AFME), a French clinical-phase MedTech company specializing in the international development and industrialization of innovative medical prostheses, announces today that TP ICAP Midcap has initiated coverage of its stock.
  • TP ICAP Midcap began covering the stock with a study entitled "Du baume au coeur" ("Heart-Warming"), published on 27 March 2024.
  • This initiation completes the coverage of Affluent Medical’s stock and adds to the financial analyst consensus alongside Invest Securities, Kepler Cheuvreux, and Portzamparc BNP Paribas Group.

EQS-News: MEDICLIN invites you to the virtual press conference on the financial statements for the year 2023

Retrieved on: 
Mercredi, avril 10, 2024
Webcast, Bank statement, Ticker, Q&A, MED, WKN

MEDICLIN (Ticker: MED; WKN 659 510) invites you to the virtual press conference on the financial statements for the year 2023.

Key Points: 
  • MEDICLIN (Ticker: MED; WKN 659 510) invites you to the virtual press conference on the financial statements for the year 2023.
  • The event will take place on
    The Management Board of MEDICLIN will report on the 2023 financial year, current developments at MEDICLIN and the outlook for 2024 in a webcast.
  • To participate in the press conference, please register at the following link:
    You will then receive the link to the webcast and the dial-in details for the telephone connection.
  • The replay of the webcast (without the Q&A session) will be available on the MEDICLIN website soon after the press conference.